[PTX] QoQ Quarter Result on 31-Dec-2016 [#Q2]

Stock
[PTX] Prescient Therapeutics Limited
Announcement Date
30-Dec-2016
Financial Year
2017
Quarter
31-Dec-2016 [#Q2]
Profit Trend
QoQ- 9.46%
YoY- -64.37%
Quarter Report
PTX's Result
PTX's Financial Summary
View:
Show?
Quarter Result
30/06/18 31/12/17 30/06/17 31/12/16 30/06/16 31/12/15 30/06/15 CAGR
Revenue 483 457 661 563 291 712 220 29.93%
PBT -1,394 -1,180 -1,544 -1,024 -1,131 -623 -1,070 9.20%
Tax 0 0 0 0 0 47 -41 -
NP -1,394 -1,180 -1,544 -1,024 -1,131 -623 -1,070 9.20%
Tax Rate - - - - - - - -
Total Cost 1,877 1,637 2,204 1,588 1,422 1,335 1,290 13.30%
Ratio Analysis
30/06/18 31/12/17 30/06/17 31/12/16 30/06/16 31/12/15 30/06/15 CAGR
NP Margin -288.47 -258.42 -233.58 -181.76 -389.42 -87.46 -486.55 -15.97%
Per Share
30/06/18 31/12/17 30/06/17 31/12/16 30/06/16 31/12/15 30/06/15 CAGR
EPS -0.01 -0.01 -0.01 -0.00 -0.01 -0.01 -0.02 -20.61%
EPS Diluted -0.01 -0.01 -0.01 -0.00 -0.01 -0.01 -0.02 -20.61%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.